FINRA has permanently barred a former Deutsche Bank advisor for alleged market manipulation regarding stock for a hedge fund client.

FINRA alleges that Edward Brokaw, who worked in Deutsche Bank’s Securities office in Greenwich, Conn., engaged in a series of illegal activities that resulted in the fluctuation of the stock value price of Monogram Biosciences Inc. [MGRM] to suit the needs of a hedge fund client, his family and himself.

Register or login for access to this item and much more

All On Wall Street content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access